$3.93
At close: Nov 21, 1:07 PM EDT
NexImmune reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of NexImmune using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2023 | 2023-11-17 | $-9.40 | $-7.50 | -25.3 % |
Jun 2023 | 2023-08-10 | $-7.25 | $-7.25 | 0.00 % |
Mar 2023 | 2023-05-15 | $-9.25 | $-11.50 | 19.6 % |
Dec 2022 | 2023-03-28 | $-16.25 | $-17.25 | 5.80 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
NexImmune (NEXI) is scheduled to report earnings on December 3, 2024. The last reported earnings were for reported on May 20, 2024 for Q1.
The Actual EPS was $-2.46, which missed the estimate of $0.00.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.